Cargando…
Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
BACKGROUND: Pancreatic cancer (PC) remains a difficult tumor to diagnose and treat. It is often diagnosed as advanced by reason of the anatomical structure of the deep retroperitoneal layer of the pancreas, lack of typical symptoms and effective screening methods to detect this malignancy, resulting...
Autores principales: | Ren, Shuai, Song, Lina, Tian, Ying, Zhu, Li, Guo, Kai, Zhang, Huifeng, Wang, Zhongqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579871/ https://www.ncbi.nlm.nih.gov/pubmed/34785894 http://dx.doi.org/10.2147/IJN.S335588 |
Ejemplares similares
-
Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer [Corrigendum]
Publicado: (2022) -
Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter]
por: Wang, Xin
Publicado: (2022) -
Glypican-1-antibody-conjugated Gd–Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer
por: Huang, Xin, et al.
Publicado: (2018) -
Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging
por: Chen, Xiao, et al.
Publicado: (2018) -
Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor
por: Chen, Hetao, et al.
Publicado: (2016)